covid UE compra remédio ineficaz?

The WHO found ‘a lack of evidence that remdesivir improved outcomes that matter to patients’ – but it has already been distributed by the EU

A panel at the World Health Organisation said the antiviral drug remdesivir was ‘ineffective’ in treating Covid-19. But tens of thousands of doses have already been distributed throughout the EU and a €1bn contract signed with Gilead

By NIKOLAJ NIELSEN

BRUSSELS, TODAY, 07:04

The European Commission has not written off remdesivir to treat Covid-19, after the drug was distributed to tens of thousands of people – despite a recent statement from the World Health Organization (WHO) that the antiviral medicine is ineffective and should not be used.

“I will not get into a scientific analysis of remdesivir, this is for science to do that,” said European Commission president Ursula von der Leyen on Friday (20 November), when pressed on the issue.